Electromed director granted 3,000 restricted shares of common stock
Electromed, Inc. reported a Form 4 insider transaction for a company director.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Electromed, Inc. reported a Form 4 insider transaction for a company director. On 12/01/2025, the director acquired 3,000 shares of common stock, coded as an "A" transaction, at a reported price of $0, indicating a grant rather than an open-market purchase. These shares are described as restricted stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated under their terms.
Following this grant, the director beneficially owned 21,000 shares of Electromed common stock in direct form. The filing is made by a single reporting person in the capacity of Director of Electromed.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted Stock scheduled to vest on June 1, 2026, unless earlier accelerated or terminated pursuant to their terms.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Electromed (ELMD) report in this Form 4?
What is the director’s relationship to Electromed (ELMD) in this filing?
Was this Electromed (ELMD) Form 4 filed jointly with other insiders?
Does this Electromed (ELMD) Form 4 involve any derivative securities?
AI-generated analysis. How Rhea-AI works. Not financial advice.